95.10
+2.00
+(2.15%)
At close: 1:30:32 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
831,921.00
767,669.00
654,383.00
654,835.00
1,056,012.00
Cost of Revenue
46,108.00
48,697.00
49,699.00
37,073.00
37,234.00
Gross Profit
785,813.00
718,972.00
604,684.00
617,762.00
1,018,778.00
Operating Expense
393,063.00
441,790.00
321,938.00
255,288.00
209,073.00
Operating Income
392,750.00
277,182.00
282,746.00
362,474.00
809,705.00
Net Non Operating Interest Income Expense
67,031.00
54,010.00
25,492.00
15,211.00
41,164.00
Pretax Income
451,101.00
337,974.00
392,465.00
545,395.00
752,475.00
Tax Provision
80,963.00
63,324.00
73,682.00
119,364.00
148,194.00
Net Income Common Stockholders
370,138.00
274,650.00
318,783.00
426,031.00
604,281.00
Diluted NI Available to Com Stockholders
370,138.00
274,650.00
318,783.00
426,031.00
604,281.00
Basic EPS
2.58
1.91
2.22
2.95
4.15
Diluted EPS
2.57
1.91
2.22
2.94
4.14
Basic Average Shares
143,331.71
143,610.00
143,596.00
144,537.00
145,623.00
Diluted Average Shares
143,928.40
143,741.00
143,696.00
144,736.00
145,898.00
Total Expenses
439,171.00
490,487.00
371,637.00
292,361.00
246,307.00
Net Income from Continuing & Discontinued Operation
370,138.00
274,650.00
318,783.00
426,031.00
604,281.00
Normalized Income
370,138.82
274,649.19
318,788.69
425,863.05
604,281.00
Interest Income
67,244.00
54,320.00
25,569.00
15,423.00
41,607.00
Interest Expense
213.00
310.00
77.00
212.00
443.00
Net Interest Income
67,031.00
54,010.00
25,492.00
15,211.00
41,164.00
EBIT
451,314.00
338,284.00
392,542.00
545,607.00
752,918.00
EBITDA
460,532.00
347,306.00
401,153.00
555,870.00
765,476.00
Reconciled Cost of Revenue
46,108.00
48,697.00
49,699.00
37,073.00
37,234.00
Reconciled Depreciation
9,218.00
9,022.00
8,611.00
10,263.00
12,558.00
Net Income from Continuing Operation Net Minority Interest
370,138.00
274,650.00
318,783.00
426,031.00
604,281.00
Total Unusual Items Excluding Goodwill
-1.00
1.00
-7.00
215.00
--
Total Unusual Items
-1.00
1.00
-7.00
215.00
--
Normalized EBITDA
460,533.00
347,305.00
401,160.00
555,655.00
765,476.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-0.18
0.19
-1.31
47.05
--
12/31/2020 - 6/20/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4147.TWO TaiMed Biologics Inc.
86.50
+0.35%
6589.TWO EirGenix Inc.
79.80
+1.01%
4743.TWO Oneness Biotech Co., Ltd.
79.70
+1.66%
6535.TWO Lumosa Therapeutics Co., Ltd.
263.50
-0.57%
6550.TW Polaris Group
43.40
+0.46%
4174.TWO OBI Pharma, Inc.
56.90
+1.25%
1760.TW Panion & Bf Biotech Inc.
82.70
+1.10%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
6712.TWO Ever Supreme Bio Technology Co., Ltd
175.50
-0.28%